Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Dietetics professor explains who should and should not embrace the latest weight-loss drugs
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an increasingly popular option to consider: GLP-1s.
How do GLP-1 drugs work for weight loss?
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame themselves for it.
Novel drug confers weight loss of up to 20% at 1 year in phase 2 study
Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to approximately 20% at 1 year in patients with overweight or obesity without a weight loss plateau,
Jonathan Van Ness Is on Weight Loss Drug Amid Binge-Eating Disorder
Jonathan Van Ness is taking weight-loss medication to help him deal with a binge-eating disorder that, he says, caused him to rapidly gain and lose weight in the past. The hairstylist and Queer Eye alum,
Jonathan Van Ness Says He's on Weight-Loss Medication to Control His Binge-Eating Disorder: 'I Have a Confession to Make'
"Yes, I am on a GLP-1 for a weight-loss medication,” the 'Queer Eye' star said Jonathan Van Ness is opening up on how weight-loss medication has been helping his binge-eating disorder. In a TikTok posted Wednesday,
Jonathan Van Ness reveals he uses weight-loss medication to control food intake
Jonathan Van Ness has revealed he has been using weight-loss medication to get his binge-eating disorder under control. The Queer Eye star, who identifies as non-binary, has revealed that he tried weight-loss medication in a pill form two years ago but it didn't work for him.
Queer Eye's Jonathan Van Ness breaks silence on using weight loss drug: 'I have a confession to make'
Jonathan Van Ness is seen on the Netflix show, Queer Eye. He has, for the first time, spoken publicly about using weight loss drugs during his fitness journey.
Medscape
2h
Are Patients On GLP-1s Getting the Right Nutrients?
As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...
TCTMD
15h
Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
The Next Web
32m
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy
The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.
Medscape
3d
Early Intervention Central to Treating Muscle Mass Loss in Patients Losing Weight With GLP-1 Meds
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
23h
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
Metro Times
2h
What Is the Ideal Semaglutide Dose for Weight Loss?
The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...
21h
on MSN
Terry Smith Sells Diageo Stock on Weight-Loss Drugs Fears
British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...
1d
Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...
22h
GLP-1 Medications Fuel Growth in Medical Aesthetics, with Weight Loss Accounting for 11% of Non-Surgical Spending in 2024
Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today revealed new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback